Poet stock initially saw a big valuation pullback as the market reacted to Broadcom's and Ciena's latest quarterly report.
Poet's share price battled back and managed to post a modest gain today.
The stock has substantial upside potential, but it looks very risky.
Poet Technologies (NASDAQ: POET) managed to post a modest gain on Thursday despite bearish trading for optics and networking technologies stocks. The company's share price closed out the day up roughly 0.6%.
Poet stock battled back from early sell-offs connected to the market's negative reaction to earnings reports from Broadcom and Ciena. The company's share price had been down as much as 10.6% early in the day's trading, but it bounced back as some investors reassessed the situation and treated the pullback as a buying opportunity.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
Broadcom published its latest quarterly report after the market closed yesterday, and Ciena published its quarterly results before the market opened this morning. While both companies posted sales and earnings that came in ahead of the average Wall Street estimates, both stocks saw dramatic pullbacks in today's trading. More strikingly, each company actually raised its full-year sales outlook.
Despite strong quarters, both companies got hit with big valuation contractions in today's trading. Broadcom ended the day down 12.6%, and Ciena was down 13.7%.
Despite trading down 25% from its 52-week high, Poet stock is still up roughly 144.5% year to date. The company now has a market capitalization of roughly $2.37 billion and is valued at approximately 235 times this year's expected sales.
While the company recently announced that it had secured a contract with Lumilens worth at least $50 million, the timeline for revenue recognition on the deal remains uncertain -- and it's possible that the figures used to calculate the company's forward price could actually significantly overestimate the business's sales for the year.
Additionally, the contract also provided Lumilens with warrants allowing it to buy shares of Poet at $8.50 per share -- a very favorable valuation. With the company's uncertain sales outlook and dilutive stock offerings in mind, I think investing in Poet carries a high degree of risk right now.
Before you buy stock in Poet Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Poet Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $439,632!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,316,532!*
Now, it’s worth noting Stock Advisor’s total average return is 959% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of June 4, 2026.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Broadcom and Ciena. The Motley Fool has a disclosure policy.